Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in the Netherlands

Obstetrics and Gynecology

Volumn 88, Issue 3, 1996, Pages 387-393

  Koper, Norbert P ^a   Kiemeney, Lambertus A L M ^b   Massuger, Leon F A G ^b   Thomas, Chris M G ^b   Schijf, Charles P T ^b   Verbeek, André L M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; OVARY CANCER; PRIORITY JOURNAL;

EID: 0029835007     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00198-6     Document Type: Article

References (42)

1. Coleman MP, Estevè J, Damiecki P, Arslan A, Renard H, eds. Trends in cancer incidence and mortality. IARC publication no. 21. Lyon, France: IARC Scientific Publications 1993.
2. Ries LAG, Hartge P, Trimble E. Ovary. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, et al, eds. SEER cancer statistics review 1973-1990. NIH publication no. 93-2789. Bethesda, Maryland: National Cancer Institute, 1993.
3. Balvert-Locht HR, Coebergh JWW, Hop WCJ, Brölmann HAM, Crommelin MA, van Wijck DJAM, et al. Improved prognosis of ovarian cancer in the Netherlands during the period 1975-1985: A registry-based study. Gynecol Oncol 1991;42:3-8.
4. Neijt JP, ten Bokkel Huinink WW, van der Burg MEL, van Oosterom AT, Willemse PHB, Vermerken JB, et al. Long-term survival in ovarian cancer: Mature data from the Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer 1991;27:1367-72.
5. Chang J, Bridgewater J, Gore M, Fisher C, Schofield J, A'Hern R, et al. Non-surgical aspects of ovarian cancer. Lancet 1994;343:335-41.
6. Averette HE, Janicek MF, Menck HR. The national cancer data base report on ovarian cancer. Cancer 1995;76:1096-103.
7. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. 1995;45:8-30.
8. Shoham Z. Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil Steril 1994;62: 433-48.
9. Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-203.
10. Harris R, Whittemore AS, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992; 136:1204-11.
11. Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol 1992;136:1212-20.
12. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994;140: 585-97.
13. Piver MS, Baker TR, Piedmonte M, Sandecki AM. Epidemiology and etiology of ovarian cancer. Semin Oncol 1991;18:177-85.
14. Adami H, Bergström R, Persson I, Sparén P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990;132: 446-52.
15. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-82.
16. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988;42:690-6.
17. Negri E, La Vecchia C, Decarli A, Boyle P. Projections to the end of the century of mortality from major cancer sites in Italy. Tumori 1990;76:420-8.
18. Brenner H, Ziegler H. Monitoring and projecting cancer incidence in Saarland, Germany, based on age-cohort analyses. J Epidemiol Community Health 1992;46:15-20.
19. Ayiomamitis A. The epidemiology of malignant neoplasms of the ovary, fallopian tube, and broad ligament in Canada: 1950-1984. Obstet Gynecol 1989;73:1017-21.
20. Villard-Mackintosh L, Vessey MP, Jones L. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age. Br J Obstet Gynaecol 1989;96:783-8.
21. Yancik R. Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 1993;71:517-23.
22. Riggs JE. Rising ovarian cancer mortality in the elderly: A manifestation of differential survival. Gynecol Oncol 1995;58:64-7.
23. Dos Santos Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995;72:485-92.
24. Stanford JL. Oral contraceptives and neoplasia of the ovary. Contraception 1991;43:543-56.
25. Visser O, Coebergh JWW, Scheuten LJ, eds. Incidence of cancer in the Netherlands 1991: Third report of the Netherlands Cancer Registry. Utrecht: Netherlands Cancer Registry, 1994.
26. World Health Organization (WHO). International classification of diseases for oncology. 1st ed. Geneva, Switzerland: WHO, 1976.
27. Hermanek P, Sobin LH, eds. TNM classification of malignant tumours. UICC international union against cancer. 4th fully revised ed. Berlin: Springer-Verlag, 1987.
28. Central Bureau of Statistics. Mortality by cause of death, 1950-1977. The Hague: Staatsuitgeverij, 1980.
29. Central Bureau of Statistics. Mortality by cause of death, age and sex in the year 1978, 1979, . . ., 1993 Series A1. The Hague: Staatsuitgeverij, 1979, 1980, . . ., 1994.
30. Smith P. Comparison between registries: Age-standardized rates. In: Muir CS, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol. V. IARC publication no. 88:709-15. Lyon, France: IARC Scientific Publications 1987.
31. Hartge P, Devesa S. Ovarian cancer, ovulation and side of origin. Br J Cancer 1995;71:642-3.
32. Central Bureau of Statistics. Compendium health statistics of the Netherlands 1979. The Hague: Staatsuitgeverij, 1980.
33. Central Bureau of Statistics. Vademecum of health statistics of the Netherlands 1993. The Hague: SDU/Publishers, 1993.
34. Central Bureau of Statistics. Vademecum of health statistics of the Netherlands 1995. The Hague: SDU/Publishers, 1995.
35. Central Bureau of Statistics. Statistical yearbook 1994. The Hague: SDU/Publishers, 1994.
36. Verweij GCG. Pill consumption is still increasing (in Dutch). Month bull health stat 1989;7:14-9.
37. Yancik R, Ries LG, Yates JW. Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data. Am J Obstet Gynecol 1986;154:639-47.
38. Ries LAG. Ovarian cancer: Survival and treatment differences by age. Cancer 1993;71:524-9.
39. Bosman JM, Lako CJ, Sturmans F, Willems JHBM. The increase of the number of hysterectomies in the Netherlands: The influence on incidence and mortality rates of cervival carcinoma (in Dutch). Ned Tijdschr Geneeskd 1983;127:900-5.
40. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and fetal ovarian cancer. Am J Epidemiol 1995;141:828-35.
41. Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975;123:772-4.
42. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995-1000.